Status:
COMPLETED
BarcelonaBeta Dementia Prevention Research Clinic: a Study on Risk Factors Disclosure
Lead Sponsor:
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Conditions:
Alzheimer Disease
Dementia
Eligibility:
All Genders
60-80 years
Phase:
NA
Brief Summary
Alzheimer's disease (AD) is the leading cause of dementia and its prevalence is estimated to exceed 100 million affects by 2050, becoming the main public health problem worldwide. Classically, AD has ...
Eligibility Criteria
Inclusion
- Participants from 60 to 80 years old
- Cognitively healthy persons with SCD as well as people with MCI.
- Participation of a relative to inform on the participant subjective memory decline and on the clinical interview.
- Understanding of the protocol and implication of risk factor disclosure
- Willing to participate in this research study and undergo the study's tests and procedures
Exclusion
- Any significant systemic illness or unstable medical condition which could lead to difficulty complying with the protocol.
- Any significant disorder that could course with cognitive impairment or subjective decline that is not related to AD.
- Investigator's criteria: subjects that show any condition that could interfere in the proper execution of the study procedures and/or in their future permanence in the study.
- Family history of monogenic AD.
Key Trial Info
Start Date :
July 16 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
306 Patients enrolled
Trial Details
Trial ID
NCT03847038
Start Date
July 16 2018
End Date
December 31 2022
Last Update
March 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barcelonabeta Brain Research Center
Barcelona, Please Choose A State, Spain, 08005